FDA's Role in Vaccine Approval During COVID-19

This chapter explores the critical function of the FDA in regulating vaccine policies and approvals throughout the COVID-19 pandemic. It examines the shift to a risk-stratified approach for booster shots, emphasizing the need for data-driven decisions and thorough clinical trials. The discussion also highlights the importance of addressing public concerns, the investigation into adverse events, and the need for flexibility and diverse opinions in vaccination strategies.